Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiaki Zaizen

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Internal Medicine (Tokyo, Japan)|July 13, 2022
Granulomatous Lymphocytic Interstitial Lung Disease in Multiple MyelomaJun Sasaki, Masaki Tominaga, Misa Sudou, et al.
Respiratory Investigation|August 1, 2025
Ability of patient-reported outcomes to predict progression-free survival in patients with mild to moderate fibrosing interstitial lung diseaseMasaki Okamoto, Toyoshi Yanagihara, Yoshiaki Zaizen, et al.
Respiratory Investigation|August 29, 2018
Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositisSatoshi Sakamoto, Masaki Okamoto, Shinjiro Kaieda, et al.
Frontiers in Immunology|February 18, 2026
Complement activation and M2-like macrophage accumulation in anti-MDA5 monoclonal antibody-induced hepatic injury in miceTakuma Koga, Yoshiaki Zaizen, Hiroyuki Suzuki, et al.
Journal of Clinical Medicine|January 8, 2025
Exercise-Induced Oxygen Desaturation and Outcomes After Nintedanib Therapy for Fibrosing Interstitial Lung Disease in Patients Without DyspneaMasaki Okamoto, Toyoshi Yanagihara, Kiminori Fujimoto, et al.
Japanese Journal of Radiology|September 3, 2020
Computed tomography findings of current nonspecific interstitial pneumonia based on the 2013 updated classification of idiopathic interstitial pneumonias: What is a characteristic of previously diagnosed nonspecific interstitial pneumonia excluded from the updated classificationJunya Tominaga, Tae Iwasawa, Makiko Murota, et al.
Japanese Journal of Radiology|October 9, 2025
Volume histogram analysis of whole-lung CT: differentiating usual from nonspecific interstitial pneumonias and predicting prognosisTomonori Chikasue, Hiromitsu Sumikawa, Akiko Sumi, et al.
Journal of Thoracic Disease|October 29, 2019
Elevation of pulmonary CD163<sup>+</sup> and CD204<sup>+</sup> macrophages is associated with the clinical course of idiopathic pulmonary fibrosis patientsTakashi Nouno, Masaki Okamoto, Koji Ohnishi, et al.
Journal of Clinical Medicine|February 13, 2025
The Impact of Adverse Events in Transbronchial Lung Cryobiopsy on Histopathological DiagnosisKenji Tsumura, Shushi Umemoto, Yoshiaki Zaizen, et al.
Medicina (Kaunas, Lithuania)|November 25, 2023
Successful Treatment of a Patient with Drug-Refractory Rheumatoid Arthritis-Associated Interstitial Lung Disease with Upadacitinib: A Case ReportYuuya Nishii, Masaki Okamoto, Yoshiaki Zaizen, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Internal Medicine (Tokyo, Japan)|July 13, 2022
Granulomatous Lymphocytic Interstitial Lung Disease in Multiple MyelomaJun Sasaki, Masaki Tominaga, Misa Sudou, et al.
Respiratory Investigation|August 1, 2025
Ability of patient-reported outcomes to predict progression-free survival in patients with mild to moderate fibrosing interstitial lung diseaseMasaki Okamoto, Toyoshi Yanagihara, Yoshiaki Zaizen, et al.
Respiratory Investigation|August 29, 2018
Low positive titer of anti-melanoma differentiation-associated gene 5 antibody is not associated with a poor long-term outcome of interstitial lung disease in patients with dermatomyositisSatoshi Sakamoto, Masaki Okamoto, Shinjiro Kaieda, et al.
Frontiers in Immunology|February 18, 2026
Complement activation and M2-like macrophage accumulation in anti-MDA5 monoclonal antibody-induced hepatic injury in miceTakuma Koga, Yoshiaki Zaizen, Hiroyuki Suzuki, et al.
Journal of Clinical Medicine|January 8, 2025
Exercise-Induced Oxygen Desaturation and Outcomes After Nintedanib Therapy for Fibrosing Interstitial Lung Disease in Patients Without DyspneaMasaki Okamoto, Toyoshi Yanagihara, Kiminori Fujimoto, et al.
Japanese Journal of Radiology|September 3, 2020
Computed tomography findings of current nonspecific interstitial pneumonia based on the 2013 updated classification of idiopathic interstitial pneumonias: What is a characteristic of previously diagnosed nonspecific interstitial pneumonia excluded from the updated classificationJunya Tominaga, Tae Iwasawa, Makiko Murota, et al.
Japanese Journal of Radiology|October 9, 2025
Volume histogram analysis of whole-lung CT: differentiating usual from nonspecific interstitial pneumonias and predicting prognosisTomonori Chikasue, Hiromitsu Sumikawa, Akiko Sumi, et al.
Journal of Thoracic Disease|October 29, 2019
Elevation of pulmonary CD163<sup>+</sup> and CD204<sup>+</sup> macrophages is associated with the clinical course of idiopathic pulmonary fibrosis patientsTakashi Nouno, Masaki Okamoto, Koji Ohnishi, et al.
Journal of Clinical Medicine|February 13, 2025
The Impact of Adverse Events in Transbronchial Lung Cryobiopsy on Histopathological DiagnosisKenji Tsumura, Shushi Umemoto, Yoshiaki Zaizen, et al.
Medicina (Kaunas, Lithuania)|November 25, 2023
Successful Treatment of a Patient with Drug-Refractory Rheumatoid Arthritis-Associated Interstitial Lung Disease with Upadacitinib: A Case ReportYuuya Nishii, Masaki Okamoto, Yoshiaki Zaizen, et al.
Pageof 9